Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

The association of variable number of tandem repeats of the insulin gene with susceptibility to type 1 diabetes among Korean subjects.

Chung HR, Yang SW, Shin CH, Park KS, Lee YA, Kim JH, Lee SH, Kim JH.

Diabetes Metab Res Rev. 2010 Sep;26(6):474-80. doi: 10.1002/dmrr.1103.

PMID:
20607677
2.

Variable number of tandem repeats of the insulin gene determines susceptibility to latent autoimmune diabetes in adults.

Cerrone GE, Caputo M, Lopez AP, González C, Massa C, Cédola N, Targovnik HM, Frechtel GD.

Mol Diagn. 2004;8(1):43-9.

PMID:
15230641
3.

HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients.

Cejkova P, Novota P, Cerna M, Kolostova K, Novakova D, Kucera P, Novak J, Andel M, Weber P, Zdarsky E.

Int J Immunogenet. 2008 Apr;35(2):133-40. doi: 10.1111/j.1744-313X.2008.00749.x. Epub 2008 Feb 11.

PMID:
18279373
4.

IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity.

Walter M, Albert E, Conrad M, Keller E, Hummel M, Ferber K, Barratt BJ, Todd JA, Ziegler AG, Bonifacio E.

Diabetologia. 2003 May;46(5):712-20. Epub 2003 May 16.

PMID:
12750767
5.

Insulin gene VNTR, CTLA-4 +49A/G and HLA-DQB1 alleles distinguish latent autoimmune diabetes in adults from type 1 diabetes and from type 2 diabetes group.

Haller K, Kisand K, Pisarev H, Salur L, Laisk T, Nemvalts V, Uibo R.

Tissue Antigens. 2007 Feb;69(2):121-7.

PMID:
17257313
6.

Effect of polymorphism in insulin locus and HLA on type 1 diabetes in four ethnic groups in Israel.

Benedek G, Brautbar C, Vardi P, Sharon N, Weintrob N, Zung A, Israel S.

Tissue Antigens. 2009 Jan;73(1):33-8. doi: 10.1111/j.1399-0039.2008.01153.x. Epub 2008 Oct 24.

PMID:
19000139
7.

The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes.

Pugliese A, Zeller M, Fernandez A Jr, Zalcberg LJ, Bartlett RJ, Ricordi C, Pietropaolo M, Eisenbarth GS, Bennett ST, Patel DD.

Nat Genet. 1997 Mar;15(3):293-7.

PMID:
9054945
8.

Insulin VNTR I/III genotype is associated with autoantibodies against glutamic acid decarboxylase in newly diagnosed type 1 diabetes.

Rajasalu T, Haller K, Salur L, Kisand K, Tillmann V, Schlosser M, Uibo R.

Diabetes Metab Res Rev. 2007 Oct;23(7):567-71.

PMID:
17461431
9.

Evidence for a Type 1 diabetes-specific mechanism for the insulin gene-associated IDDM2 locus rather than a general influence on autoimmunity.

Tait KF, Collins JE, Heward JM, Eaves I, Snook H, Franklyn JA, Barnett AH, Todd JA, Maranian M, Compston A, Sawcer S, Gough SC.

Diabet Med. 2004 Mar;21(3):267-70.

PMID:
15008838
10.

[IDDM and variable number of tandem repeats (VNTR) in the 5'region of the insulin gene: a review].

Awata T.

Nihon Rinsho. 1997 Oct;55 Suppl:376-81. Review. Japanese. No abstract available.

PMID:
9392134
11.

The variable number of tandem repeats upstream of the insulin gene is a susceptibility locus for latent autoimmune diabetes in adults.

Desai M, Zeggini E, Horton VA, Owen KR, Hattersley AT, Levy JC, Hitman GA, Walker M, Holman RR, McCarthy MI, Clark A.

Diabetes. 2006 Jun;55(6):1890-4.

12.
13.

Autoimmune responses to the beta cell autoantigen, insulin, and the INS VNTR-IDDM2 locus.

Sarugeri E, Dozio N, Belloni C, Meschi F, Pastore MR, Bonifacio E.

Clin Exp Immunol. 1998 Dec;114(3):370-6.

14.

Impact of IDDM2 on disease pathogenesis and progression in children with newly diagnosed type 1 diabetes: reduced insulin antibody titres and preserved beta cell function.

Nielsen LB, Mortensen HB, Chiarelli F, Holl R, Swift P, de Beaufort C, Pociot F, Hougaard P, Gammeltoft S, Knip M, Hansen L; Hvidøre Study Group.

Diabetologia. 2006 Jan;49(1):71-4. Epub 2005 Nov 23.

PMID:
16307231
15.

Association between INS-VNTR polymorphism and polycystic ovary syndrome in a Korean population.

Yun JH, Gu BH, Kang YB, Choi BC, Song S, Baek KH.

Gynecol Endocrinol. 2012 Jul;28(7):525-8. doi: 10.3109/09513590.2011.650658. Epub 2012 Apr 2.

PMID:
22468791
16.

Strong association of insulin gene INS-VNTR polymorphisms with type 1 diabetes in the Romanian population.

Guja C, Guja L, Nutland S, Rance H, Todd JA, Ionescu-Tîrgovişte C.

Rom J Intern Med. 2004;42(2):313-23.

PMID:
15529622
17.

Polymorphism -23HPhI in the promoter of insulin gene and pancreatic cancer: a pilot study.

Krechler T, Jachymova M, Pavlikova M, Vecka M, Zeman M, Krska Z, Svestka T, Zak A.

Neoplasma. 2009;56(1):26-32.

PMID:
19152242
18.

Large-scale studies of the HphI insulin gene variable-number-of-tandem-repeats polymorphism in relation to Type 2 diabetes mellitus and insulin release.

Hansen SK, Gjesing AP, Rasmussen SK, Glümer C, Urhammer SA, Andersen G, Rose CS, Drivsholm T, Torekov SK, Jensen DP, Ekstrøm CT, Borch-Johnsen K, Jørgensen T, McCarthy MI, Hansen T, Pedersen O.

Diabetologia. 2004 Jun;47(6):1079-87. Epub 2004 May 29.

PMID:
15170498
19.

The relation between size at birth and risk of type 1 diabetes is not influenced by adjustment for the insulin gene (-23HphI) polymorphism or HLA-DQ genotype.

Stene LC, Thorsby PM, Berg JP, Rønningen KS, Undlien DE, Joner G; Norwegian Childhood Diabetes Study Group.

Diabetologia. 2006 Sep;49(9):2068-73. Epub 2006 May 12.

PMID:
16691379
20.

Mechanisms of genetic susceptibility to type I diabetes: beyond HLA.

Anjos S, Polychronakos C.

Mol Genet Metab. 2004 Mar;81(3):187-95. Review.

PMID:
14972324

Supplemental Content

Support Center